Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
β Scribed by Paul L. Nguyen; Ming-Hui Chen; Clair J. Beard; W. Warren Suh; Toni K. Choueiri; Jason A. Efstathiou; Karen E. Hoffman; Marian Loffredo; Philip W. Kantoff; Anthony V. D'Amico
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 156 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostateβspecific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio
## Abstract Among men who experience prostateβspecific antigen (PSA) failure after external beam radiation or brachytherapy (RT), many will harbor occult micrometastases; however, a significant minority will have a true localβonly failure and, thus, potentially may benefit from a salvage local ther
## Background: The authors previously found that, although the total percentage of prostate needle biopsy cores with carcinoma was a significant predictor of prostate specific antigen (psa) failure among men undergoing radical prostatectomy (rp), there was a trend toward a lower risk of recurrence